Star Imaging And Path Lab P/E Ratio

Current P/E Ratio
5.3
Low Valuation
Very Low - Potentially undervalued or facing challenges

Star Imaging And Path Lab P/E ratio. Star Imaging And Path Lab (STARIMAGIN) P/E ratio is 5.3 (Low), EPS (TTM) ₹11.05, current price ₹ on None — Very Low - Potentially undervalued or facing challenges. Also explore STARIMAGIN price movement history to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 5.3
Current Price ₹
EPS (TTM) ₹11.05
Exchange None

Valuation Signal

Signal Undervalued

Sector Context

Sector Average 52.4
Sector Median 29.6
Sector Rank #9 of 255
Sector Percentile 3.5%

STARIMAGIN P/E Ratio — Valuation Signal & Historical Context

Star Imaging And Path Lab P/E 5.3 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see Star Imaging And Path Lab screener.

  • Stock appears undervalued with PE of 5.3, suggesting potential buying opportunity
  • Trading at discount to sector average PE of 52.4

STARIMAGIN vs Healthcare Peers — P/E Ratio Comparison

Star Imaging And Path Lab P/E 5.3 vs Healthcare average 52.4, median 29.6 — range 2.0–733.0.

Sector Average
52.4
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Kabra Drugs KABRADG 6.3 ₹49 Low
Colinz Laboratories COLINZ 6.5 ₹17 Low